Abstract
Opioids are a group of compounds that interact at the opioid receptors that are primarily used acute and chronic pain relief. There are many different opioids that differ in their mode of action, duration of action, abuse potential, adverse effects, route of administration, and potency.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- CNCP:
-
Chronic non-cancerous pain
- COT:
-
Chronic opioid therapy
- ECGs:
-
Electrocardiograms
- ER:
-
Extended release
- GABA:
-
Gamma-aminobutyric acid
- IR:
-
Immediate release
- MHRA:
-
Medicines and Healthcare products Regulatory Agency
- QTc:
-
Rate corrected QT
- SL:
-
Sublingual
References
Breasted JG. Ancient records of Egypt. University of Chicago Oriental Institute Publications. vol. III. Chicago: University of Chicago Press; 1930. p. 217.
Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician. 2008;11:S5–62 [opioids special issue].
Warner EA. Opioids for the treatment of noncancer pain. Am J Med. 2012;125(12):1155–61.
Nestler EJ. Molecular basis on longterm plasticity underlying addiction. Nat Rev Neurosci. 2001;2:119–28.
Fukuda K. Intravenous opioid anesthetics. In: Miller RD, editor. Miller’s anesthesia. 6th ed. Philadelphia: Elsevier; 2005.
Martell BA, O’Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR, Fiellin DA. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146(2):116–27.
Noble M, Treadwell JR, Treager SJ, Coates VH, Wiffen PJ, Akafomo C, Schoelles KM. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;1, CD006605.
Title 12, Chapter 13, Part B12: Schedules of controlled substances. DEA. www.ibt.tamhsc.edu/safety_office/pdf_stuff/DEA-Sch_%20of_Cont_Sub.Pdf
Chou R, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–30.
Manchikanti L, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 1—evidence assessment. Pain Physician. 2012;15:S1–66.
Manchikanti L, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2—guidance. Pain Physician. 2012;15:S66–116.
Ackerman SJ, Knight T, Schein J, et al. Risk of constipation in patients prescribed fentanyl transdermal system or oxycodone hydrochloride controlled-release in a California Medicaid population. Consult Pharm. 2004;19:118–32.
Verhamme KM, Sturkenboom MC, Stricker BH, Bosch R. Drug-induced urinary retention: incidence, management and prevention. Drug Saf. 2008;31(5):373–88.
Ganesh A, Maxwell LG. Pathophysiology and management of opioid-induced pruritis. Drugs. 2007;67(16):2323–32.
Swegle JM, Logemann C. Management of common opioid-induced adverse effects. Am Fam Physician. 2006;74(8):1347–54.
Lee M, Silverman S, Hansen H, Patel V, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14:145–61.
Kishner S. Opioid equivalents. eMedicine from WebMD, August 7; 2012.
Derby S, Chin J, Portenoy RK. Systemic opioid therapy for chronic cancer pain: practical guidelines for converting drugs and routes of administration. CNS Drugs. 1999;9(2):99–109.
Jaffe JH, Martin WR. Opioid analgesics and antagonists. In: Gilman AG, Goodman LS, Rall TW, et al., editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 7th ed. New York: Macmillan Publishing Company; 1985. p. 491–531.
MHRA and Commission on Human Medicines. Risk of QT interval prolongation with methadone. Report no.: 31; 2006.
Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol. 1993;72:23B–5B.
Katchman AN, McGroary KA, Kilborn MJ, et al. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents. J Pharmacol Exp Ther. 2002;303:688–94.
Mayet S, Gossop M, Lintzeris N, Markides V, Strang J. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? Drug Alcohol Rev. 2011;30(4):388–96.
Kahn LH, Alderfer RJ, Graham DJ. Seizures reported with Tramadol. JAMA. 1997;278:1661.
Lewis JW. Buprenorphine. Drug Alcohol Depend. 1985;14:363–72.
Tzschentke TM, Christoph T, Kögel B, Schiene K, Hennies HH, Englberger W, Haurand M, Jahnel U, Cremers TI, Friderichs E, De Vry J. Tapentadol HCl: a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties. J Pharmacol Exp Ther. 2007;323(1):265–76.
Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112–20.
Ferrel B, Argoff CE, Epplin J, Fine P, Gloth 3rd FM, Herr K, Katz JD, Mehr DR, Reid MC, Reisner L. American geriatrics society panel on the pharmacological management of persisting pain in older persons. Pain Med. 2009;10(6):1062–83.
Brookoff D. Abuse potential of various opioid medications. J Gen Intern Med. 1993;8(12):688–90.
Alford D, Compton P, Samet J. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006;144(2):127–34.
Kehlet H, Dahl JB. The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. Anesth Analg. 1993;77:1048–56.
Botney M, Fields HL. Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol. 1983;13:160–4.
Mitra S, Sinatra RS. Perioperative management of acute pain in the opioid-dependent patient. Anesthesiology. 2004;101:212–27.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kishner, S., Tran, J.P. (2015). Opioid Medications. In: Sackheim, K. (eds) Pain Management and Palliative Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2462-2_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2462-2_14
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2461-5
Online ISBN: 978-1-4939-2462-2
eBook Packages: MedicineMedicine (R0)